Your browser doesn't support javascript.
loading
Biological disease-modifying anti-rheumatic drugs are equally effective in psoriatic arthritis patients with low and high joint counts.
Möller, Burkhard; Scholz, Godehard A; Amsler, Jennifer; Ciurea, Adrian; Micheroli, Raphael; Nissen, Michael J; Papagiannoulis, Eleftherios; Blapp, Christoph; Scherer, Almut; Yawalkar, Nikhil.
Afiliación
  • Möller B; Department of Rheumatology and Immunology, Inselspital, University Hospital of Berne, Berne, Switzerland.
  • Scholz GA; Department of Rheumatology and Immunology, Inselspital, University Hospital of Berne, Berne, Switzerland.
  • Amsler J; Department of Rheumatology and Immunology, Inselspital, University Hospital of Berne, Berne, Switzerland.
  • Ciurea A; Department of Rheumatology, University Hospital of Zurich, Zurich, Switzerland.
  • Micheroli R; Department of Rheumatology, University Hospital of Zurich, Zurich, Switzerland.
  • Nissen MJ; Department of Rheumatology, University Hospital of Geneva, Geneva, Switzerland.
  • Papagiannoulis E; Swiss Clinical Quality Management (SCQM) Foundation, Zurich, Switzerland.
  • Blapp C; Swiss Clinical Quality Management (SCQM) Foundation, Zurich, Switzerland.
  • Scherer A; Swiss Clinical Quality Management (SCQM) Foundation, Zurich, Switzerland.
  • Yawalkar N; Department of Dermatology, Inselspital, University Hospital of Berne, Berne, Switzerland.
Article en En | MEDLINE | ID: mdl-37676822

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Guideline / Prognostic_studies Idioma: En Revista: Rheumatology (Oxford) Asunto de la revista: REUMATOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Suiza

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Guideline / Prognostic_studies Idioma: En Revista: Rheumatology (Oxford) Asunto de la revista: REUMATOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Suiza